Pharma Journalist - Page 915 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

Synthon Biopharmaceuticals Enters Worldwide Exclusive License and Collaboration with Sanquin

Otsuka Pharmaceutical to Acquire Neurovance, Inc.

Integral Molecular and Integrated BioTherapeutics Initiate Collaboration for Virus Vaccine Discovery

Glenmark Pharmaceuticals and Evestra, Inc. Announce Partnership Agreement for Generic NuvaRing

Lilly Completes Acquisition of CoLucid Pharmaceuticals

RegeneRx Licensee Receives FDA Permission to Conduct a Phase 3 Trial of RGN-137

Arsanis Inc., and Adimab Enter Into License Agreement

Perrigo Signs Agreement To Divest Tysabri Royalty Stream For Up To $2.85 Billion

Enrollment Completed in Ligand’s Phase 2 Trial of LGD-6972 in Type 2 Diabetes

Intellipharmaceutics Announces FDA Approval for 500 mg and 750 mg Generic Glucophage XR